ArticleFrontiers in immunology2021

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.

Yanzhu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.